Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Psychometric Analyses to Inform Item Reduction and Evaluate Sensitivity of the Early Mobility Impairment Questionnaire for Multiple Sclerosis.
MS Research Roundup: January 15, 2014
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.
Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
Astrocytes in multiple sclerosis.
Papers: 31 Jul 2014 - 7 Aug 2014
Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
Episode 83 with Dr. Jerry Wolinsky on composite clinical trial outcome measures
All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
3-Year Average Delay in Identifying SPMS Transition
Chronic pain disrupts the reward circuitry in multiple sclerosis.

Pages